MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.bbrc.2024.151155

Медицинская библиотека · Biochemical and biophysical research communications · 2024

PEG-modification enhances the targeted photothermal therapy of affibody-conjugated indocyanine green for precision cancer treatment.

Liu Yanting, Bai Xuerui, Wang Henan, Wang Jian, Li Shuang, Zhang Hongru, Wang Fengwei, Hong Zhangyong

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Photothermal therapy (PTT) is an innovative cancer treatment that leverages heat generated from near-infrared light exposure to induce tumor cell death. A major challenge in PTT is achieving precise delivery of the photothermal agent to tumor tissues to maximize efficacy and minimize off-target effects. In this study, we introduce a novel ligand-coupled photothermal reagent that addresses this challenge by leveraging the high-affinity HER2 affibody ZHER2:2891 (referred to as ZHER2), conjugated with indocyanine green (ICG) for targeted delivery. Polyethylene glycol (PEG) was incorporated as a hydrophilic linker to further optimize photothermal conversion efficiency and enhance tumor-specific targeting. Among the conjugates tested, ZHER2-PEG1000-ICG, modified with a PEG chain of 1000 Da molecular weight, demonstrated exceptional performance. In vitro studies revealed that ZHER2-PEG1000-ICG specifically bound to HER2-expressing cells and effectively induced cell death. In vivo experiments using HER2-positive N87 tumor-bearing mice showed that ZHER2-PEG1000-ICG accumulated highly and specifically in tumor tissues over an extended period. Upon light irradiation, this conjugate caused a significant rise in temperature at the tumor site, resulting in complete tumor elimination with a single photothermal treatment. This PEG-modified affibody-ICG conjugate represents a precise and effective approach to PTT, offering a promising new therapeutic strategy for cancer treatment with the potential to significantly impact future cancer therapies.

Для цитирования: Liu Yanting, Bai Xuerui, Wang Henan, Wang Jian, Li Shuang, Zhang Hongru, Wang Fengwei, Hong Zhangyong. PEG-modification enhances the targeted photothermal therapy of affibody-conjugated indocyanine green for precision cancer treatment.. Biochemical and biophysical research communications. 2024. DOI: 10.1016/j.bbrc.2024.151155.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.